Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.

Blood 2013 Oct 26;122(17):2943-64. Epub 2013 Aug 26.

Department of Hematology and Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo, and.

Within the myelodysplastic syndrome (MDS) work package of the European LeukemiaNet, an Expert Panel was selected according to the framework elements of the National Institutes of Health Consensus Development Program. A systematic review of the literature was performed that included indexed original papers, indexed reviews and educational papers, and abstracts of conference proceedings. Guidelines were developed on the basis of a list of patient- and therapy-oriented questions, and recommendations were formulated and ranked according to the supporting level of evidence. MDSs should be classified according to the 2008 World Health Organization criteria. An accurate risk assessment requires the evaluation of not only disease-related factors but also of those related to extrahematologic comorbidity. The assessment of individual risk enables the identification of fit patients with a poor prognosis who are candidates for up-front intensive treatments, primarily allogeneic stem cell transplantation. A high proportion of MDS patients are not eligible for potentially curative treatment because of advanced age and/or clinically relevant comorbidities and poor performance status. In these patients, the therapeutic intervention is aimed at preventing cytopenia-related morbidity and preserving quality of life. A number of new agents are being developed for which the available evidence is not sufficient to recommend routine use. The inclusion of patients into prospective clinical trials is strongly recommended.

Download full-text PDF

Source
http://www.leukemia-net.org/content/leukemias/mds/recommenda
Web Search
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2013-03-49
Publisher Site
http://dx.doi.org/10.1182/blood-2013-03-492884DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3811170PMC
October 2013
33 Reads

Publication Analysis

Top Keywords

european leukemianet
8
cell transplantation
4
list patient-
4
basis list
4
transplantation high
4
high proportion
4
developed basis
4
stem cell
4
patient- therapy-oriented
4
recommendations formulated
4
intensive treatments
4
treatments allogeneic
4
questions recommendations
4
allogeneic stem
4
therapy-oriented questions
4
guidelines developed
4
proportion mds
4
educational papers
4
curative treatment
4
reviews educational
4

Altmetric Statistics

References

(Supplied by CrossRef)

Swerdlow et al.
2008
No increase in age-specific incidence of myelodysplastic syndromes.
Germing et al.
Haematologica 2004
A patient-oriented approach to treatment of myelodysplastic syndromes.
Cazzola et al.
Haematologica 1998
Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology.
Alessandrino et al.
Haematologica 2002

Similar Publications